Back to TRDA
GOLDMAN SACHS GROUP INC → TRDA
GOLDMAN SACHS GROUP INC TRDA Position History
Entrada Therapeutics, Inc. • Healthcare
Quarters held
14
Latest value
$508K
Q3 2026
Peak value
$1.6M
First seen
Q2 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2025 | $215K |
| Q2 2025 | $350K |
| Q3 2025 | $807K |
| Q3 2025 | $483K |
| Q4 2025 | $914K |
| Q4 2025 | $1.2M |
| Q4 2025 | $1.2M |
| Q4 2025 | $914K |
| Q1 2026 | $1.6M |
| Q1 2026 | $1.1M |
| Q2 2026 | $1M |
| Q2 2026 | $283K |
| Q3 2026 | $1.4M |
| Q3 2026 | $508K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $508K | 80.1K | — | — |
| Q3 2026 | $1.4M | 218.1K | — | — |
| Q2 2026 | $283K | 38.4K | — | — |
| Q2 2026 | $1M | 138.9K | — | — |
| Q1 2026 | $1.1M | 85.7K | — | — |
| Q1 2026 | $1.6M | 127.0K | — | — |
| Q4 2025 | $914K | 88.9K | — | — |
| Q4 2025 | $1.2M | 116.3K | — | — |
| Q4 2025 | $1.2M | 116.3K | — | — |
| Q4 2025 | $914K | 88.9K | — | — |
| Q3 2025 | $483K | 83.2K | — | — |
| Q3 2025 | $807K | 139.1K | — | — |
| Q2 2025 | $350K | 52.1K | — | — |
| Q2 2025 | $215K | 32.0K | — | — |